Implementing Prescribing Guidelines for Atypical Antipsychotics to Reduce Metabolic Effects

Background: Atypical antipsychotics have become the standard prescribing therapy for mental health treatment. Metabolic conditions such as weight gain and increased glucose measures have been a consistent concern with the use of these medications. Objective: An evidence-based practice change was initiated by implementing the Prescribing Guidelines for Atypical Antipsychotics to evaluate the effect of the guidelines on weight, waist circumference, blood pressure, fasting blood glucose, and fasting lipid profile. Methods: Implementation of the prescribing guidelines prompted the provider to assess weight, waist circumference, blood pressure, fasting blood glucose, and fasting lipid profile and monitor changes in these variables. Results: There were 23 patients who completed the 12-week data collection, and data analysis provided statistically significant results. The study revealed that utilization of the interventional tool can reduce metabolic effects by increased monitoring of the measures within the tool. Conclusions: Patients can have decreased long-term metabolic effects of atypical antipsychotics when providers utilize structured guidelines to monitor the side effects of these medications. Implications for Nursing: Providers must complete initial and ongoing assessments of patients initiated on atypical antipsychotic medications and also patients currently taking these medications to assess for side effects as well as ensure treatment response.